Suppr超能文献

治疗反应性双相情感障碍女性的月经相关症状变化

Menstrually related symptom changes in women with treatment-responsive bipolar disorder.

作者信息

Karadag Figen, Akdeniz Fisun, Erten Evrim, Pirildar Sebnem, Yucel Basak, Polat Aslihan, Atmaca Murad

机构信息

Bakirkoy State Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.

出版信息

Bipolar Disord. 2004 Jun;6(3):253-9. doi: 10.1111/j.1399-5618.2004.00112.x.

Abstract

OBJECTIVE

In the present study, we aimed to evaluate menstrually related symptom changes in euthymic women with treatment-responsive bipolar disorder (BD) compared with healthy control subjects and investigate the presence of premenstrual dysphoric disorder (PMDD).

METHODS

Thirty-four euthymic women with treatment-responsive BD on mood-stabilizers (lithium and/or valproate) for at least 6 months and 35 control subjects with no history of medical/mental disorder between ages of 18 and 35 years with regular menstrual cycles were prospectively followed up for at least two consecutive menstrual cycles using the Daily Record of Severity of Problems-Short Form (DRSP). Each subject was administered the retrospective self-report questionnaire, Premenstrual Assessment Form (PAF), in the first postmenstrual phase of the menstrual cycle. Venous blood samples were collected between 19 and 22 days of menstrual cycle to evaluate ovulation by measuring the serum progesterone levels.

RESULTS

The differences in mean age, age of onset of menses, cycle length and bleeding length did not appear to be significantly meaningful between groups. In the retrospective assessment of premenstrual symptom changes, controls complained more than women with BD. More controls showed a 30% change in DRSP and in depressive and physical sub-groups than the women with BD. Controls demonstrated a significant increase compared with treatment-responsive BD patients in total, depressive, anxiety and attention sub-group scores of DRSP from the postmenstrual to the premenstrual phase, whereas the scores of vegetative symptoms of controls and women with BD did not differ significantly during one cycle or both. Significant menstrual cycle effect was observed in both groups.

CONCLUSION

Within the limitations of the study, the results suggest that ongoing mood-stabilizing treatment may have a prophylactic effect against premenstrual symptom changes in women with treatment-responsive BD.

摘要

目的

在本研究中,我们旨在评估与健康对照受试者相比,患有治疗反应性双相情感障碍(BD)的心境正常女性月经相关症状的变化,并调查经前烦躁障碍(PMDD)的存在情况。

方法

34名患有治疗反应性BD且服用心境稳定剂(锂盐和/或丙戊酸盐)至少6个月的心境正常女性,以及35名年龄在18至35岁之间、月经周期规律且无医学/精神疾病史的对照受试者,使用问题严重程度每日记录简表(DRSP)进行前瞻性随访,至少连续两个月经周期。在月经周期的第一个月经后期,对每位受试者进行回顾性自我报告问卷——经前评估表(PAF)。在月经周期的第19至22天采集静脉血样,通过测量血清孕酮水平评估排卵情况。

结果

两组之间的平均年龄、月经初潮年龄、周期长度和出血长度差异似乎无显著意义。在经前症状变化的回顾性评估中,对照组比BD女性抱怨更多。与BD女性相比,更多对照组在DRSP以及抑郁和身体亚组中显示出30%的变化。与治疗反应性BD患者相比,对照组在月经后期到经前期DRSP的总分、抑郁、焦虑和注意力亚组得分显著增加,而对照组和BD女性的植物神经症状得分在一个周期或两个周期内无显著差异。两组均观察到显著的月经周期效应。

结论

在本研究的局限性内,结果表明持续的心境稳定治疗可能对患有治疗反应性BD的女性经前症状变化具有预防作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验